# Celecoxib

## Celebrex 200mg

| TAH Drug Code      | [OCEL2](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OCEL2)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Relief of the signs and symptoms of osteoarthritis and RA. Management of acute pain and treatment of primary dysmenorrhea. To reduce the number of adenomatous colorectal polyps in familial adenomatous polyposis (FAP), as an adjunct to usual care. Ankylosing spondylitis.                                                                                                                                                                                                                                                                                               |
| Dosing             | Osteoarthritis: 200mg QD, or 100mg BID Rheumatoid arthritis: 100-200mg BID Ankylosing Spondylitis (AS):200mg/day in single (once a day) or divided (twice a day) dose. If it doesn't work after six weeks, try 400 mg/day. If there is no effect after another 6 weeks, there will be no therapeutic response, and other treatments should be considered. Relieve acute pain and treat primary dysmenorrhea: initial dose: 400mg, then 200 mg twice a day when needed.                                                                                                       |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Contraindications  | Hypersensitivity to sulfonamides. Patients in whom aspirin or other NSAIDs induce symptoms of asthma, urticaria or allergic-type reactions.                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Adverse Effects    | Abdominal pain, diarrhea, dyspepsia, flatulence, peripheral edema, dizziness, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, rash. Cardiovascular: Hypertension (arthritis, 2.4% ; familial adenomatous polyposis, 12.5% ) Gastrointestinal: Diarrhea (arthritis, 5.6%; familial adenomatous polyposis, 10.5%; juvenile rheumatoid arthritis, 4% to 5% ), Nausea (arthritis, 3.5%; familial adenomatous polyposis, 6.8%; juvenile rheumatoid arthritis, 4% to 7% ) Neurologic: Headache (arthritis, 15.8%; juvenile rheumatoid arthritis, 10% to 13% ) |
| Pregnancy          | Human Data Suggest Risk in 1st and 3rd Trimesters                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |

